Editorial Board
Barbara Rath
Pediatric Head, Pediatric Infectious Diseases & Vaccines, Charité University Medical Center, Department of Pediatrics, Division of Pneumonooy-Immunology · GERMANY
Editorial leadership for Journal of Advanced Pharmaceutical Science And Technology ISSN 2328-0182
Research interests
- Vaccination
- Virology
- Immunization
- Child Health
- Respiratory Viruses
- Infection Control
Biography
- Chair of the Vienna Vaccine Safety Initiative
- Barbara is co-founder and chair of the Vienna Vaccine Safety Initiative (ViVI: www.vi-vi.org), an international think tank and non-profit organization focused on infectious disease research and communication.
- ViVI is a founding member of the International Association of Innovation Professionals and an institutional member of the European Forum for Good Clinical Practice.
- In collaboration with the School of Design Thinking in Potsdam, Germany, and the Clinical Data Interchange Standards Consortium in Austin, USA, her team developed innovative mobile-health applications to improve quality of care, with a focus on children and their families.
- During the peak of the refugee arrivals to Germany in 2015, ViVI collaborated with Psychologische Hochschule Berlin to assess health needs among refugee children and adolescents.
- Barbara is a board-certified pediatrician with profound experience in clinical and translational research in the US, Latin America and Europe.
- She attended medical school in Germany, Spain and the US, and obtained her doctoral degrees in Switzerland and France.
- In addition to an infectious disease fellowship at Stanford, she has received pediatric residency and infectious disease subspecialty training at Duke and Tulane Universities, USA.
- Barbara is Honorary Professor at the University of Nottingham School of Medicine, UK.
Considering JAPST for your work?
This journal is guided by Barbara Rath (Pediatric Head, Pediatric Infectious Diseases & Vaccines, Charité University Medical Center, Department of Pediatrics, Division of Pneumonooy-Immunology) and a peer-review board of practising researchers. Open access, author-retained copyright (CC BY), and a clear editorial process.